Alopecia Areata

Oral Therapy: Janus kinase (TYK) 2/JAK1 inhibitor; Placebo (PF-06651600 or PF-0670084)

Do you meet these requirements?

  • Male or female
  • Ages 12-75
  • ≥50% hair loss of the scalp, including alopecia totalis (AT) and alopecia universalis (AU)
  • Diagnosed with moderate to severe AA with no other etiology of hair loss (eg, telogen efflubium) other than androgenetic alopecia

14 visits during a 49 week period; Travel reimbursement-$85 per visits.

The Derm Group Location: Verona, NJ

For more information, call 1-(973)571-2121 ext. 5920 or email ctrials@thedermgroup.com

Or Contact The Verona Research Hotline 1-201-478-9119 Call or Text

The medication, procedures, and all study visits are provided without financial costs to you.  No insurance coverage is required.  All enrolled participants will be compensated for their time and travel at the completion of the study.

Back to Top